openPR Logo
Press release

Influenza Medication Market set for rapid growth forecst 2019-2026| Key Players: Alvogen , Amneal Pharmaceuticals LLC , Teva Pharmaceutical Industries Ltd. , Seqirus (CSL) , GlaxoSmithKline plc , Genentech Inc. , Macleods Pharmaceuticals Ltd. , Lupin Limi

05-17-2020 07:33 PM CET | Health & Medicine

Press release from: Fortune Business Insights

Influenza Medication Market

Influenza Medication Market

The global influenza medication market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing global burden of influenza will be one of the central forces driving the growth of this market. Influenza, or the flu, is a virus that infects the human respiratory system, that is, the throat, lungs, and nose. Usually, the infection subsides on its own, but sometimes it can turn severe and even prove to be fatal. According to the World Health Organization (WHO), every year influenza epidemics around the globe affect around 3 million to 5 million people and cause respiratory deaths between 290,000 and 650,000. The developed nations are also bearing the impact of this deadly virus. For instance, the US Centers for Disease Control and Prevention (CDC) states that since 2010, the occurrence of influenza-related illnesses in the US have been between 9 million and 45 million. In 2016-17, the CDC estimates that hospitalizations resulting from influenza alone will be around 500,000. Thus, such exponential rise in the prevalence of this infection will raise the influenza treatment market demand in the coming years.

In its new report, titled "Influenza Medication Market Size, Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B),By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies,Others) and Regional Forecast, 2019-2026", Fortune Business Insights(TM) states that the value of this market stood at USD 889.2 million in 2018.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/influenza-medication-market-101843

The report covers :
o Global influenza medication market trends, with detailed analysis on consumer trends & manufacturer trends.
o Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
o Key areas of investments identifying market opportunities and challenges in forecast time frame.
o Competitive analysis of the industry players along with the overview on strategic management.
o Comprehensive company profiles of the major industry players.

An Overview of the Impact of COVID-19 on this Market :
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].

Please visit : https://www.fortunebusinessinsights.com/industry-reports/influenza-medication-market-101843

Leading Players operating in the Influenza Medication Market are :

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
o Alvogen
o Amneal Pharmaceuticals LLC
o Teva Pharmaceutical Industries Ltd.
o GlaxoSmithKline plc
o Seqirus (CSL)
o Genentech, Inc.
o Macleods Pharmaceuticals Ltd.
o Zydus Pharmaceuticals, Inc. (Zydus Cadila)
o Lupin Limited
o BIOCRYST PHARMACEUTICALS, INC.
o Shionogi & Co., Ltd.

Rising Threat from Risk Factors for Influenza to Propel the Market
Prominent among the influenza medication market trends is the threats posed by the risk factors inducing or worsening the effects of influenza infection in humans. According to the CDC, the people most at risk for flu complications include pregnant women, diabetics, asthmatics, adults aged 65 or older, young children, HIV/AIDS patients, cancer patients, and people suffering from chronic lung or heart condition. For example, congestive heart condition in a person can worsen if she contracts the flu infection. The influenza drugs market growth is further bolstered by the rising prevalence of these risk factors. For instance, the WHO estimates that approximately 235 million people worldwide are living with asthma currently, while 18.1 million new cancer cases were reported worldwide in 2018, the WHO states.

Strong Support to R&D Activities to Fuel the Market in North America
North America is anticipated to dominate the influenza medication market share in the forecast period as the region generated a revenue of USD 527.3 million in 2018. Financial and regulatory support to academic institutions and private companies for R&D for studying influenza virus mutations will be the primary growth factor for the market in the region. Other than this, high incidence of different types of influenza along with rising awareness about the disease will also expand the regional market.
Government initiatives, increasing disposable income, and growing awareness about the dangers of the infection will accelerate the influenza medication market revenue in Asia-Pacific. In Europe, influenza research is gathering momentum which is driving the market in the region, while in the Middle East and Africa, availability of subsidized drugs will augment the market.

Have Any Query? Ask Our Experts :
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/influenza-medication-market-101843

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Medication Market set for rapid growth forecst 2019-2026| Key Players: Alvogen , Amneal Pharmaceuticals LLC , Teva Pharmaceutical Industries Ltd. , Seqirus (CSL) , GlaxoSmithKline plc , Genentech Inc. , Macleods Pharmaceuticals Ltd. , Lupin Limi here

News-ID: 2048323 • Views: 209

More Releases from Fortune Business Insights

How COVID-19 Impacting Cardiovascular Devices Market? Key Players: Terumo Cardio …
The global cardiovascular devices market size is prognosticated to reach USD 82.20 billion by 2026 on account of the increasing cases of cardiovascular diseases such as coronary artery disease, heart failure, congenital heart disease, heart attack, cardiomyopathy, and others. The increasing geriatric population and their vulnerability towards various chronic diseases, especially heart diseases is a major factor propelling the cardiovascular devices market growth. This information is published in a recent
How COVID-19 Impacting Animal Health Market ? Top Key Players : Emergent BioSolu …
The global animal health market size is anticipated to reach USD 67.56 billion by 2026 owing to the increasing number of animal health issues worldwide. Animals have always been of immense help to man either as companions or as livestock. With time, man starting adopting animals and keeping them as pets. Animals, a like humans, are susceptible to infections and diseases and require medical aid. As per a recently published
Growth Dynamics on Biomarkers Market 2019-2026| Key Players: Abbott , R&D System …
The global biomarkers market is set to gain traction from their increasing usage in a wide variety of applications, namely, drug discovery and development, safety assessment, and medicine. Besides, numerous biotech and pharmaceutical companies are persistently investing huge sums in the research and development activities. The increasing prevalence of cancer is also one of the crucial factors that would affect the market positively during the forecast period. The above information
Diabetes Drugs Market 2020 Industry Analysis By Size, Growth Rate, Trends And Ke …
Diabetes Drugs Market 2020 Global Industry Analysis by Size, Share, Trends and Growth Forecast to 2026, is latest report published on “Global Diabetes Drugs Market Size, Share and Industry Analysis By Type (Cart-based, Compact/Point-of-Care, Hand-held), By Application (Radiology, Cardiology, Gynecology, Others), By End-User (Hospitals, Clinics, Diagnostic Centers, Others), and Regional Forecast 2018-2025. Diabetes Drugs Market 2020 report presents a comprehensive assessment of the global Diabetes Drugs market by offering valuable insights,

All 5 Releases


More Releases for Influenza

Influenza Diagnostics Market – Screening Product Awareness 2025
Global Influenza Diagnostics Market: Snapshot The global market for influenza diagnostics is slated to expand at a promising pace in the next few years as the incidences of influence are rising at a massive pace on the globe front. A common illness of the respiratory system, the condition is responsible for between 250,000 to 500,000 deaths across the globe every year. As the virulent spread of the condition creates increased concerns
Influenza B Infection Market Endeavors Growth 2025
Global Influenza B Infection Market: Snapshot Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Uprising European Influenza Vaccine Market- Ken Research
Europe is at the heart of global vaccine research and production. Influenza is a vaccine preventable disease and influenza vaccine has been available for use in Europe since 1960’s. Approximately, at US$ 1 billion, Europe influenza market was closed. Nevertheless, the highest influenza market share was held by United Kingdom. West Europe has more than US$ 500 Million. United Kingdom, Germany, France, Italy and Spain hold 80 percent of influenza market
Global Influenza Vaccine Market Forecast
Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza Vaccinated Population will increase in forecast period. United States has the highest market share in Influenza Vaccine Market. United States Influenza Vaccine
Influenza Diagnostics Market Analysis – 2024
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about